Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4826
PUT
Semtech
SMTC
$11.9B
| $483K | ﹤0.01% |
10,700
-17,700
| -62% | -$630K |
|
4827
Verrica Pharmaceuticals
VRCA
$84.9M
| $481K | ﹤0.01% |
90,708
+51,143
| +129% | +$275K |
|
4828
Montauk Renewables
MNTK
$259M
| $480K | ﹤0.01% |
216,078
+193,185
| +844% | +$409K |
|
4829
Nano X Imaging
NNOX
$67.8M
| $479K | ﹤0.01% |
92,639
-8,480
| -8% | -$43.2K |
|
4830
MKS Inc
MKSI
$18.3B
| $479K | ﹤0.01% |
4,816
-540,293
| -99% | -$43.9M |
|
4831
CervoMed
CRVO
$40.1M
| $478K | ﹤0.01% |
+76,080
| New | +$648K |
|
4832
CALL
Neogen
NEOG
$2.54B
| $478K | ﹤0.01% |
+100,000
| New | +$574K |
|
|
CNL
4833
Collective Mining Ltd
CNL
$1.53B
| $478K | ﹤0.01% |
43,677
-72,198
| -62% | -$732K |
|
4834
American Vanguard Corp
AVD
$66.1M
| $475K | ﹤0.01% |
121,218
-153,179
| -56% | -$639K |
|
4835
CALL
Antero Midstream
AM
$10.4B
| $474K | ﹤0.01% |
25,000
-48,600
| -66% | -$868K |
|
4836
Alvotech
ALVO
$1.8B
| $472K | ﹤0.01% |
51,709
+22,836
| +79% | +$214K |
|
4837
CALL
Aptiv
APTV
$9.68B
| $471K | ﹤0.01% |
6,900
-193,500
| -97% | -$12M |
|
4838
CALL
Immunocore
IMCR
$1.93B
| $471K | ﹤0.01% |
+15,000
| New | +$466K |
|
4839
Community Bank
CBU
$3.31B
| $467K | ﹤0.01% |
8,220
-25,397
| -76% | -$1.41M |
|
4840
Eledon Pharmaceuticals
ELDN
$282M
| $465K | ﹤0.01% |
171,669
-639,207
| -79% | -$1.92M |
|
4841
Star Group
SGU
$412M
| $464K | ﹤0.01% |
39,658
+27,377
| +223% | +$337K |
|
4842
CALL
Modine Manufacturing
MOD
$9.99B
| $463K | ﹤0.01% |
4,700
| – | – |
|
4843
Gaotu Techedu
GOTU
$410M
| $463K | ﹤0.01% |
128,223
-1,867,921
| -94% | -$6.41M |
|
4844
Lyell Immunopharma
LYEL
$380M
| $462K | ﹤0.01% |
52,229
+50,081
| +2,332% | +$456K |
|
4845
PUT
BWX Technologies
BWXT
$13.7B
| $461K | ﹤0.01% |
3,200
-5,000
| -61% | -$584K |
|
4846
CALL
HEICO Corp
HEI
$49.1B
| $459K | ﹤0.01% |
1,400
-3,900
| -74% | -$1.08M |
|
|
MLNK
4847
DELISTED
MeridianLink
MLNK
| $456K | ﹤0.01% |
28,092
+17,897
| +176% | +$299K |
|
4848
Riot Platforms
RIOT
$7.99B
| $455K | ﹤0.01% |
40,291
-213,699
| -84% | -$1.82M |
|
|
CVAC
4849
DELISTED
CureVac
CVAC
| $455K | ﹤0.01% |
83,805
-1,733,179
| -95% | -$6.87M |
|
4850
Century Therapeutics
IPSC
$393M
| $454K | ﹤0.01% |
+812,213
| New | +$436K |
|
Similar funds
Israel Englander's Q2 2025 Portfolio in Review
As of Q2 2025, Israel Englander held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Israel Englander added most to Applovin in Q2 2025, an estimated $751M increase.
- Israel Englander's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Israel Englander fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Israel Englander's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Israel Englander opened 738 new positions and closed 712 in Q2 2025.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.